Edwards Lifesciences Patents – Key Insights and Stats

Edwards Lifesciences has a total of 1532 patents globally, out of which 879 have been granted. Of these 1532 patents, more than 62% patents are active. United States Of America is where Edwards Lifesciences has filed the maximum number of patents, followed by Europe and Germany. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Edwards Lifesciences.

Edwards Lifesciences was founded in 1958 by Lowell Edwards. Edwards Lifesciences designs, develops, and markets products and services for the treatment of cardiovascular diseases. The Company provides transcatheter heart and surgical heart valves, heat valve repair, cardiac cannula, hemodynamic monitoring, pressure monitoring, vascular surgery, and investigational devices. Edwards Lifesciences serves customers worldwide. As of April 2022 Edwards Lifesciences has a market cap of $75.48 Billion.

Do read about some of the most popular patents of Edwards Lifesciences which have been covered by us in this article and also you can find Edwards Lifesciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Edwards Lifesciences patent portfolio.

How many patents does the Founder and CEO of Edwards Lifesciences have?

The Founder & CEO, Lowell Edwards and Michael A Mussallem has 61 and 0 patents respectively.

How many patents does Edwards Lifesciences have?

Edwards Lifesciences has a total of 1532 patents globally. These patents belong to 316 unique patent families. Out of 1532 patents, 958 patents are active.

How Many Patents did Edwards Lifesciences File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantEdwards Lifesciences Applications FiledEdwards Lifesciences Patents Granted
20107727
20115726
20125531
20137044
201412039
20157145
20169866
20174668
20188275
20196384
202069105
20215587
202223

How many Edwards Lifesciences patents are Alive/Dead?

Worldwide Patents

How Many Patents did Edwards Lifesciences File in Different Countries?

Countries in which Edwards Lifesciences Filed Patents

CountryPatents
United States Of America588
Europe209
Germany120
Canada99
China72
Australia67
Japan62
Singapore25
Spain24
Israel23
Hong Kong (S.A.R.)21
Austria21
Costa Rica14
India10
United Kingdom9
Korea (South)9
Brazil8
Mexico6
Denmark5
Portugal5
South Africa3
Lithuania2
Slovenia2
Poland2
Sweden2
Croatia1
New Zealand1
Hungary1
Serbia1
Turkey1

Where are Research Centers of Edwards Lifesciences Patents Located?

10 Best Edwards Lifesciences Patents

US6730118B2 is the most popular patent in the Edwards Lifesciences portfolio. It has received 2140 citations so far from companies like Cook Inc and Micardia Corporation.

Below is the list of 10 most cited patents of Edwards Lifesciences:

Publication NumberCitation Count
US6730118B22140
US6893460B21477
US6908481B21404
US6582462B11027
US8523881B21000
US6723038B1953
US7510575B2935
US7585321B2915
US6764510B2893
US6406420B1886

Which Companies are using Edwards Lifesciences Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Edwards Lifesciences patent portfolio are Boston Scientific, Medtronic and St Jude Medical Cardiology Division.

List of the top forward citing Companies –

CompanyNumber Of Patents
Boston Scientific50
Medtronic42
St Jude Medical Cardiology Division40
Medtronic Vascular17
Bioventrix14
Tendyne Holdings13
Twelve10
Colibri Heart Valve10
Volcano10
St Jude Medical9

Count of 102 and 103 Type Rejections based on Edwards Lifesciences Patents

Top Edwards Lifesciences Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US6730118B232
US7510572B230
US8182530B227
US7510575B222
US8403983B221
US6908481B221
US8579964B221
US7803185B218
US20060241745A117
US8414644B217

What Percentage of Edwards Lifesciences US Patent Applications were Granted?

Edwards Lifesciences (Excluding its subsidiaries) has filed 306 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 242 have been granted leading to a grant rate of 82.03%.

Below are the key stats of Edwards Lifesciences patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Edwards Lifesciences?

Law FirmTotal ApplicationsSuccess Rate
Bozicevic Field & Francis2669.23%
Finnegan Henderson Farabow Garrett & Dunner140.00%
Hartman Global9100.00%
Adsero6100.00%
Edwards Lifesciences Llc4100.00%
Novadaq Technologies Inc425.00%
Polsinelli40%
Joseph F Shirtz333.33%
Stryker European Operations3100.00%
Bd Rutan & Tucker250.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are Synopsys’ key innovation segments?

What Technologies are Covered by Synopsys?

The chart below distributes patents filed by Synopsys in different countries on the basis of the technology protected in patents. It also represents the markets where Synopsys thinks it’s important to protect particular technology inventions.

R&D Focus: How has Synopsys’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Synopsys?

Updated on April 30, 2022

Was this article helpful?

Leave a Comment